Torrent Pharmaceuticals Share Price Rise 5.15%: Q3 Profit Jumps, ₹29 Dividend Declared

Torrent Pharmaceuticals Ltd share price rose 5.15% to ₹4,287.90 on 16 February at 9:34 AM IST, compared with the previous close of ₹4,078.00 on the NSE. The stock gained ₹209.90 in early trade following the company’s December quarter earnings announcement.

The move came after the company reported a 26% year-on-year rise in consolidated net profit to ₹635 crore for Q3 FY25 and declared a dividend of ₹29 per equity share, as per its regulatory filing. Revenue from operations stood at ₹3,303 crore for the quarter, up 17.6% year-on-year.

Why Torrent Pharmaceuticals Share Price Rose

The upward movement followed the company’s reported improvement in profitability and revenue growth for the December quarter. Net profit increased from ₹503 crore in the corresponding quarter last year to ₹635 crore, while revenue rose from ₹2,809 crore to ₹3,303 crore.

Sequentially, profit improved from ₹591 crore in the September quarter, reflecting margin expansion. Meanwhile, the company announced an interim dividend of ₹29 per equity share of ₹5 fully paid up. The dividend may be paid on or around 6th March, 2026.

Torrent Pharmaceuticals Stock Performance Snapshot

As of 9:34 AM IST on 16 February, Torrent Pharmaceuticals shares traded at ₹4,287.90 on the NSE, up 5.15% from the previous close of ₹4,078.00. The stock opened at ₹4,144.30 and touched a high of ₹4,304.90 and a low of ₹4,118.00 so far during the session.

The stock’s 52-week high stood at ₹4,315, while the 52-week low was ₹2,886.45. The price-to-earnings (P/E) ratio was 63.88, based on exchange data.

What this Means for Investors

The December quarter performance indicates continued revenue growth and improvement in bottom-line performance. The 26% rise in net profit and double-digit revenue growth may reflect operational efficiency and demand momentum across segments.

The dividend declaration of ₹29 per share suggests the company maintained a shareholder payout policy alongside earnings expansion. Investors may track margin sustainability, domestic and international market performance, and regulatory developments in upcoming quarters.

Broader Market and Sectoral Context

The stock’s 5%+ gain positioned it among notable gainers in early trade. Broader market indices were trading with moderate movement during the session, while pharmaceutical stocks witnessed selective buying interest following earnings updates across the sector.

Peer movements in the pharmaceutical segment remained mixed, based on NSE data in early trade.

Torrent Pharmaceuticals shares advanced 5.15% in early trade on 16 February after the company reported a 26% year-on-year increase in Q3 FY25 net profit to ₹635 crore and announced a ₹29 per share dividend. Revenue growth of 17.6% year-on-year and sequential improvement in profitability supported investor reaction, with the stock trading near its 52-week high in morning trade.

Source: https://www.nseindia.com/get-quote/equity/TORNTPHARM/Torrent-Pharmaceuticals-Limited